Sign In
Buy CANF
$3.12
+0.0100 (+0.322%)
At Close: Jun 03, 2026
Can-Fite Announces $8.0 Million Registered Direct Offering
12:00pm, Wednesday, 10'th Jun 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today
Following Pre-IND Guidance From FDA Can-Fite To Advance Piclidenoson Into Phase II COVID-19 Trial In The US
11:04am, Tuesday, 09'th Jun 2020Following Pre-IND Guidance from FDA Can-Fite to Advance Piclidenoson into Phase II COVID-19 Trial in the U.S.
11:00am, Tuesday, 09'th Jun 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announ
Can-Fite Participating in BIO Digital International Convention And One-on-One Partnering Meetings On June 8-12, 2020
11:26am, Monday, 08'th Jun 2020Can-Fite Participating in BIO Digital International Convention and One-on-One Partnering Meetings on June 8-12, 2020
11:25am, Monday, 08'th Jun 2020
Can-Fite Participating in BIO Digital International Convention and One-on-One Partnering Meetings on June 8-12, 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today
Can-Fite BioPharma to Hold Investor Webinar and Q&A Session with CEO on June 4th
11:00am, Wednesday, 03'rd Jun 2020
Can-Fite BioPharma to Hold Investor Webinar and Q&A; Session with CEO on June 2nd
Can Fite Biofarma shares are trading lower after the company reported worse-than-expected Q1 sales results.
01:06pm, Monday, 01'st Jun 2020Can-Fite Biopharma Q1 EPS $(0.03) Beats $(0.66) Estimate, Sales $198.00K Miss $1.18M Estimate
11:09am, Monday, 01'st Jun 2020Can-Fite Reports First Quarter 2020 Financial Results & Provides Clinical Update
11:00am, Monday, 01'st Jun 2020
Can-Fite Reports First Quarter 2020 Financial Results & Provides Clinical Update
Can-Fite BioPharma Ltd. to Host Earnings Call
10:30am, Monday, 01'st Jun 2020
NEW YORK, NY / ACCESSWIRE / June 1, 2020 / Can-Fite BioPharma Ltd. (AMEX:CANF) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on June 1, 2020 at 8:30 AM
Can-Fite to Host First Quarter 2020 Financial Results & Clinical Update Conference Call on June 1, 2020
11:00am, Thursday, 28'th May 2020
Can-Fite to Host First Quarter 2020 Financial Results & Clinical Update Conference Call on June 1, 2020
